Award recordCONTRACT

LEADIANT BIOSCIENCES, INC.

PIID 36E79722A0005· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $0 net obligations· UEI XEEKF6DJLC34· MD

Description

2026 PUBLIC LAW PRICING UPDATES.

Base award description: BPA FOR MATULANE

First action · last action
2021-10-20 · 2025-11-20
Transactions
13
First transaction's obligation
$0
Base + all options value (sum of deltas)
$465,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79721D0236
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 13 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2021-10-20 · this action $0 · running total $0Modification P00001 · 2021-12-28 · this action $0 · running total $0Modification P00002 · 2022-05-09 · this action $0 · running total $0Modification P00003 · 2022-09-19 · this action $0 · running total $0Modification P00004 · 2022-12-19 · this action $0 · running total $0Modification P00005 · 2023-09-20 · this action $0 · running total $0Modification P00006 · 2023-09-20 · this action $0 · running total $0Modification P00007 · 2023-12-12 · this action $0 · running total $0Modification P00008 · 2024-10-03 · this action $0 · running total $0Modification P00010 · 2024-12-05 · this action $0 · running total $0Modification P00011 · 2024-12-05 · this action $0 · running total $0Modification P00012 · 2025-10-15 · this action $0 · running total $0Modification P00013 · 2025-11-20 · this action $0 · running total $0
  • Base2021-10-20+$0= $0
  • Mod P000012021-12-28+$0= $0
  • Mod P000022022-05-09+$0= $0
  • Mod P000032022-09-19+$0= $0
  • Mod P000042022-12-19+$0= $0
  • Mod P000052023-09-20+$0= $0
  • Mod P000062023-09-20+$0= $0
  • Mod P000072023-12-12+$0= $0
  • Mod P000082024-10-03+$0= $0
  • Mod P000102024-12-05+$0= $0
  • Mod P000112024-12-05+$0= $0
  • Mod P000122025-10-15+$0= $0
  • Mod P000132025-11-20+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-10-20+$0$0BPA FOR MATULANE
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-12-28+$0$02022 PUBLIC LAW PRICING UPDATES
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-05-09+$0$0PRODUCT ADD (CYSTARAN)
Mod P00003· EXERCISE AN OPTION2022-09-19+$0$0EXERCISE THE FIRST OPTION YEAR ON BPA 36E79722A0005
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-12-19+$0$02023 PUBLIC LAW UPDATES
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-09-20+$0$0INCORPORATE A PRICE INCREASE ON ONE CYSTARAN NDC.
Mod P00006· EXERCISE AN OPTION2023-09-20+$0$0EXERCISE OPTION YEAR 2
Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-12-12+$0$02024 PUBLIC LAW PRICE UPDATES
Mod P00008· EXERCISE AN OPTION2024-10-03+$0$0EXERCISE OPTION YEAR 3
Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-12-05+$0$02025 PUBLIC LAW PRICING UPDATES
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-12-05+$0$02025 PUBLIC LAW PRICING UPDATES
Mod P00012· EXERCISE AN OPTION2025-10-15+$0$0EXERCISE THE 4TH AND FINAL OPTION YEAR
Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-11-20+$0$02026 PUBLIC LAW PRICING UPDATES.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI XEEKF6DJLC34)

AwardOffice · PSC / listingNet obligationsFY
36F79721D0236NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2021
36C24920N0493249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$5,443FY2020
36C26320F0037NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS$5,443FY2020
36C24919N0474249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$5,351FY2019
36C24919N0265249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$3,945FY2019
36C24119N0132241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$23,669FY2019

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79722A0005_3600 · retrieved 2026-09-26.